Jidabokuippo use in patients with fractures of the extremities

Aims

Jidabokuippo (JDI) is a traditional Japanese medicine used for alleviating contusion-induced swelling and pain. Usually, nonsteroidal anti-inflammatory drugs (NSAIDs) are used for the treatment of swelling and pain associated with fractures of the extremities. However, one disadvantage of NSAIDs use is their potential to cause gastrointestinal problems, even in patients concomitantly treated with anti-ulcer drugs. In this study, we assessed the effectiveness of JDI in patients with fractures of the extremities.

Methods

Fifty patients (15 men and 35 women) with fractures of the extremities were recruited into the study. All participants were treated using non-invasive methods and administered JDI alone within 3 days of injury. The effectiveness of JDI was assessed following administration by evaluating the need for NSAIDs or other medication. In addition, adverse reactions were monitored.

Results

Comorbidities were present in 42% of the study participants. The mean duration of treatment was 9.9 ± 6.7 days (range 1–35 days). Forty-four patients did not require any medication other than JDI, testifying to its effectiveness. Five participants had their medication switched to NSAIDs, and one patient had eppikajutsuto added to the JDI treatment. In summary, 90% of the patients were effectively treated with traditional Japanese medicines. No adverse reactions were observed.

Conclusion

This study suggests that JDI can be used more widely for fractures of the extremities.